Inactive Instrument

Ekso Bionics Holdings Inc Stock OTC Bulletin Board

Equities

EKSO

US2826442020

Advanced Medical Equipment & Technology

Sales 2024 * 20.52M Sales 2025 * 28.1M Capitalization 19.99M
Net income 2024 * -9M Net income 2025 * -4M EV / Sales 2024 * 0.97 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.71 x
P/E ratio 2024 *
-2.14 x
P/E ratio 2025 *
-4.58 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.79%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 54 21-03-31
Director of Finance/CFO 50 17-04-30
Chief Operating Officer 52 -
Members of the board TitleAgeSince
Director/Board Member 56 21-12-24
Director/Board Member 69 20-12-28
Director/Board Member 39 18-03-10
More insiders
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
More about the company